Furthermore, treatment of HepG2 hepatoma cells with 3 mM metformin impaired ATP synthesis, while overexpression of SIRT3 increased ATP content in a dose-dependent manner and partially counteracted metformin effect (Fig. 3b). Here, SIRT3 is linked to hepatocellular carcinoma.